Pharmaceuticals

Precision Fluidics Market Size, Share & Trends Analysis Report By Component (Pumps, Valves, Probes, Degassers, Fluidic Systems, Manifolds, Pressure Sensors, Flow Sensors, Fluid Level Sensors, Inline Filters, Subsystem Level-Fluidics Systems or Integration), By Application, By Region, And By Segment Forecasts, 2024-2031

The Precision Fluidics Market Size is valued at USD 6.79 Billion in 2023 and is predicted to reach USD 12.63 Billion by the year 2031 at an 8.20 % CAGR during the forecast period for 2024-2031. Key Industry Insights & Findings from the Report: The expanding use of microfluidics in point-of-care diagnostics and the miniaturization of devices for improved efficiency are further propelling market growth. The lack of awareness and ...

Report ID: 1405  |  

Delivery: Immediate  |  

Published: April 2024   |  

No. of Pages: 175

Novel Drug Delivery Systems In Cancer Therapy Market Size, Share & Trends Analysis Report By Product (Nanoparticles, Embolization Particles), By Region, And by Segment Forecasts, 2024-2031

The Novel Drug Delivery Systems In Cancer Therapy Market Size is valued at USD 12.71 Billion in 2023 and is predicted to reach USD 63.25 Billion by the year 2031 at a 22.41 % CAGR during the forecast period for 2024-2031. Key Industry Insights & Findings from the Report: The ability of novel drug delivery systems to deliver targeted therapies provides opportunities for personalized medicine. Advances in targeted therapies, including...

Report ID: 1440  |  

Delivery: Immediate  |  

Published: April 2024   |  

No. of Pages: 175

Cervical Spondylosis Diagnosis & Treatment Market Size, Share & Trends Analysis Report By Diagnosis (Imaging Tests, Neck X-ray, MRI, CT Myelography, Nerve Function Tests, Electromyography, Nerve Conduction Study), By Product Type (Medications, Medical Devices, Surgical Instruments), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, And By Segment Forecasts, 2024-2031.

Cervical Spondylosis Diagnosis & Treatment Market Size is valued at USD 6.19 Bn in 2023 and is predicted to reach USD 10.14 Bn by the year 2031 at a 6.3% CAGR during the forecast period for 2024-2031. Cervical spondylosis is a degenerative disorder that affects the neck region and is treated with therapy. These therapies reduce discomfort, boost mobility, and forestall nerve and spinal cord degeneration. Pain and stiffness can be experienc...

Report ID: 2430  |  

Delivery: Immediate  |  

Published: April 2024   |  

No. of Pages: 179

Shoulder Replacement Market Size, Share & Trends Analysis Report By Type (Anatomical Shoulder Prosthesis, Reverse Shoulder Prosthesis), By Procedure (Resurfacing Hemiarthroplasty, Reverse Total Shoulder Replacement, Stemmed Hemiarthroplasty, Total Shoulder Replacement), By End-User (Hospitals, Orthopedic Centers, Others), By Region, And By Segment Forecasts, 2023-2031.

Shoulder Replacement Market Size is valued at USD 1.55 Bn in 2022 and is predicted to reach USD 2.62 Bn by the year 2031 at a 6.10% CAGR during the forecast period for 2023-2031. Shoulder arthroplasty, also known as shoulder replacement surgery, involves replacing the ball and sometimes the socket of the shoulder joint using a prosthesis composed of metal and polyethylene components. This surgical procedure is referred to as shoulder arthropla...

Report ID: 2155  |  

Delivery: Immediate  |  

Published: April 2024   |  

No. of Pages: 179

Pitavastatin Market Size, Share & Trends Analysis Report, By Type (1 mg, 2 mg and 5 mg), By Product Type (Tablets, Capsules and Oral Solution), By Application (Hyperlipidemia and Cardiovascular Disease Prevention), By End-user (Hospitals, Clinics, Retail Pharmacies, And Online Pharmacies), By Region, Forecasts, 2024-2031

Pitavastatin Market Size was valued at USD 537.1 Mn in 2023 and is predicted to reach USD 890.2 Mn by 2031 at a 6.7% CAGR during the forecast period for 2024-2031. The increasing awareness of preventive healthcare measures and the significance of managing cardiovascular risk factors are driving the demand for pitavastatin as a preventive medication. Opportunities exist to expand the global reach of the pitavastatin market, tap into emerging ma...

Report ID: 2421  |  

Delivery: Immediate  |  

Published: March 2024   |  

No. of Pages: 179

Ocular Inflammation Treatment Market Size, Share & Trends Analysis Report By Treatment Type (Corticosteroids, Antibiotics, Monoclonal Antibodies, Immunosppressant, Cycloplegic Agents, Antivirals, Antifungal, Analgesics), By Disease Type, By Mode of Administration, By Distribution Channel, By Region, And By Segment Forecasts, 2024-2031

Ocular Inflammation Treatment Market Size is valued at USD 428.7 Mn in 2023 and is predicted to reach USD 690.4 Mn by the year 2031 at a 6.31% CAGR during the forecast period for 2024-2031. Ocular inflammation, often known as Uveitis, is managed with antibiotic eye drops, tablets, or immunosuppressive medications. The therapy of ocular inflammation focuses on lowering inflammation, relieving pain, and preventing damage to the tissues. Treatmen...

Report ID: 2407  |  

Delivery: Immediate  |  

Published: March 2024   |  

No. of Pages: 180

DTC Wellness Testing Market Size, Share & Trends Analysis Report By Type (Genetic Testing, Metabolic Testing, Nutritional Testing, Hormone Testing, Others), By Application (Disease Risk Assessment, Ancestry Testing, Fitness and Nutrition, Personalized Medicine, Others), By Product, By Technology, Region And Segment Forecasts, 2024-2031

Global DTC Wellness Testing Market Size is valued at USD 973.30 Mn in 2023 and is predicted to reach USD 3,518.77 Mn by the year 2031 at a 17.79% CAGR during the forecast period for 2024-2031. The global market for (DTC) genetic testing encompasses regions where genetic testing services and products are directly marketed and sold to consumers, bypassing medical professionals or intermediaries. DTC genetic testing enables individuals to obtain ...

Report ID: 2317  |  

Delivery: Immediate  |  

Published: March 2024   |  

No. of Pages: 180

Genome Editing/Genome Engineering Market Size, Share & Trends Analysis Report By Technology (CRISPR, TALEN, ZFN, Antisense, and Other Technologies), By Products, By Application, By End Users, Region And Segment Forecasts, 2023-2031.

The Genome Editing/Genome Engineering Market Size is valued at 5900.0 Million in 2022 and is predicted to reach 28469.3 Million by the year 2031 at a 19.20 % CAGR during the forecast period for 2023-2031. Genome engineering is the technique that involves gene modification by certain process include DNA is insertion, cutting, modification or replacement of genome of a living organism. Due to increasing the research and development spend by comp...

Report ID: 1174  |  

Delivery: Immediate  |  

Published: March 2024   |  

No. of Pages: 180

Microbiome Diagnostics Market Size, Share & Trends Analysis Report By Product (Reagents & Kits, Instruments), By Technology (16S rRNA Sequencing, Shot Gun Metagenomics, Metatranscriptomics, Other Technology), By Sample (Feces, Saliva, Skin, Other Sample), By Application (Disease Diagnostics Application (Gastrointestinal Disorders, Metabolic Diseases, Other Application), Research Application), By End-User (Hospitals, Academic and Research Institutes, Biotechnology and Pharmaceutical Companies), By Region, And By Segment Forecasts, 2024-2031

Microbiome Diagnostics Market Size is valued at USD 154.9 Mn in 2023 and is predicted to reach USD 488.2 Mn by the year 2031 at a 15.6% CAGR during the forecast period for 2024-2031. Utilizing advanced genomic and bioinformatic techniques, these diagnostics can profile microbial DNA from samples (e.g., gut, skin, oral cavity) to understand the composition and function of the microbiome. Applications range from disease diagnosis and risk assess...

Report ID: 2398  |  

Delivery: Immediate  |  

Published: March 2024   |  

No. of Pages: 179

Alpha 1 Lung Disease Market Size, Share & Trends Analysis Report By Disease Type (Alpha-1 Antitrypsin Deficiency, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Fibrosis, Bronchiectasis, Others), By Treatment Type (Augmentation Therapy, Bronchodilators, Corticosteroids, Oxygen Therapy, Lung Transplantation, Others), By Route of Administration, By Distribution Channel, By End User, By Region, And By Segment Forecasts, 2023-2031.

Alpha 1 Lung Disease Market Size is valued at USD 4.13 Billion in 2022 and is predicted to reach USD 19.93 Billion by the year 2031 at a 19.33% CAGR during the forecast period for 2023-2031. Alpha-1 Antitrypsin Deficiency is a genetic disorder in which the body does not make enough of a protein known as alpha-1 antitrypsin. This protein is very important for keeping the lungs safe from damage caused by inflammation. People who don't get enough...

Report ID: 2274  |  

Delivery: Immediate  |  

Published: March 2024   |  

No. of Pages: 180